US · CGC
Canopy Growth Corporation
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Smiths Falls, ON K7A 0A8
- Website
- canopygrowth.com
Price · as of 2025-03-31
$1.13
Market cap 576.26M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $6.60 | +484.07% |
| Intrinsic Value(DCF) | $0.68 | -39.82% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $3.40 | +200.88% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $0.30 | $0.00 | |||
| 2012 | |||||
| 2013 | $0.10 | ||||
| 2014 | $0.00 | ||||
| 2015 | |||||
| 2016 | $20.70 | $3,070.67 | $0.80 | $0.00 | |
| 2017 | $58.30 | $55.70 | $714,120.63 | $1.70 | $0.00 |
| 2018 | $304.90 | $145.47 | $0.00 | $2.30 | $0.00 |
| 2019 | $421.90 | $196.96 | $4.01 | $4.40 | $0.00 |
| 2020 | $165.10 | $83.30 | $0.00 | $0.00 | $0.00 |
| 2021 | $258.70 | $115.79 | $0.00 | $0.00 | $0.00 |
| 2022 | $36.50 | $14.60 | $0.00 | $3.10 | $24.40 |
| 2023 | $6.80 | $2.72 | $0.00 | $0.00 | $1,040.50 |
| 2024 | $7.03 | $31.80 | $0.00 | $0.00 | $10.20 |
| 2025 | $1.70 | $9.24 | $0.00 | $0.00 | $3.40 |
AI valuation
Our deep-learning model estimates Canopy Growth Corporation's (CGC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $6.60
- Current price
- $1.13
- AI upside
- +484.07%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.68
-39.82% upside
Graham-Dodd
—
— upside
Graham Formula
$3.40
+200.88% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| CGC | Canopy Growth Corporation | $1.13 | 576.26M | +718% | -40% | — | +201% | -0.42 | 0.52 | 0.95 | -0.99 | — | 0.72 | 29.56% | -43.55% | -222.35% | -122.35% | -14.04% | -54.48% | 0.72 | -1.57 | 3.12 | 1.95 | -0.49 | -3709.00% | -947.00% | -3809.00% | -69.30% | -1.76 | -21.21% | 0.00% | 0.00% | 102.99% | -4.03 | -2.67 | 1.76 | -16.18 |
| ACB | Aurora Cannabis Inc. | $3.84 | 217.76M | +498% | -40% | +80% | -82% | 27.82 | 0.78 | 1.28 | 6.97 | — | 0.92 | 54.65% | 1.44% | 0.46% | 2.80% | 0.80% | 1.87% | 0.18 | 0.59 | 4.31 | 2.06 | -1.56 | -10223.00% | 2701.00% | -9666.00% | -0.65% | 0.15 | -0.59% | 0.00% | 0.00% | 0.12% | 72.30 | -125.35 | 1.04 | -8.43 |
| ACRS | Aclaris Therapeutics, Inc… | $2.87 | 310.95M | +859% | -54% | — | +777% | -5.76 | 3.63 | 47.81 | -3.46 | — | 3.63 | 73.28% | -975.91% | -829.58% | -50.20% | 2416.55% | -34.10% | 0.00 | — | 5.28 | 5.28 | 0.31 | -6901.00% | -5819.00% | 13383.00% | -12.62% | -1.64 | 1494.19% | 0.00% | 0.00% | 0.00% | -2.92 | -4.72 | 28.46 | -5.14 |
| BIOA | BioAge Labs, Inc. | $22.27 | 798.49M | — | — | — | — | -0.69 | 0.15 | — | 4.33 | — | 0.15 | 0.00% | — | — | -94.98% | 95.18% | -37.02% | 0.03 | -33.04 | 12.86 | 12.76 | 5.04 | -2246.00% | — | 3826.00% | -106.31% | -1.85 | 63.16% | 0.00% | 0.00% | 772.94% | 3.80 | 5.72 | — | 0.23 |
| CABA | Cabaletta Bio, Inc. | $3.32 | 319.6M | — | — | — | — | -0.79 | 0.60 | — | 0.51 | -1.89 | 0.60 | 0.00% | — | — | -59.64% | -6352.34% | -52.82% | 0.10 | -167.30 | 6.15 | 6.05 | 1.35 | 4182.00% | — | 6674.00% | -98.71% | -3.26 | -4590.51% | 0.00% | 0.00% | 0.00% | 0.45 | 0.63 | — | -2.29 |
| DH | Definitive Healthcare Cor… | $1.28 | 132.23M | +1,820% | +27% | — | — | -0.61 | 0.32 | 0.50 | 0.32 | — | -1.85 | 75.88% | -8.52% | -57.52% | -48.41% | -6.39% | -21.84% | 0.02 | -1.82 | 1.64 | 1.49 | 0.96 | -6328.00% | -424.00% | -1918.00% | 30.48% | 0.34 | 12.09% | 0.00% | 0.00% | 290.32% | 2.50 | -1.39 | -0.21 | 0.60 |
| IRWD | Ironwood Pharmaceuticals,… | $3.42 | 556.36M | +1,376% | -58% | -88% | — | 24.11 | -10.55 | 1.96 | 5.51 | 0.21 | -10.18 | 99.36% | 40.10% | 8.11% | -13.49% | 62.48% | 6.42% | -3.88 | 3.63 | 1.13 | 1.08 | -0.03 | 1171818.00% | -1572.00% | 2283.00% | 21.93% | 0.52 | 167.05% | 0.00% | 0.00% | 88.68% | 4.85 | 4.54 | 1.95 | 2.60 |
| LFCR | Lifecore Biomedical, Inc. | $7.20 | 269.76M | +1,115% | -61% | — | — | -6.29 | 182.17 | 1.89 | -41.53 | — | -14.53 | 31.27% | -13.38% | -30.04% | -612.08% | -13.25% | -15.70% | 97.92 | -0.79 | 2.84 | 1.72 | -13.91 | -48485.00% | 47.00% | -2490.00% | -5.60% | -0.01 | -10.46% | 0.00% | 0.00% | 1.05% | -21.22 | -26.87 | 2.84 | -0.01 |
| LYEL | Lyell Immunopharma, Inc. | $24.00 | 509.85M | -75% | -75% | — | +4,553% | -0.57 | 0.51 | 3184.91 | 0.58 | -1.41 | 0.51 | 100.00% | -588122.95% | -562285.25% | -66.10% | -295.08% | -55.28% | 0.15 | — | 7.06 | 6.89 | 0.23 | 4014.00% | -5308.00% | -212.00% | -83.83% | -3.02 | -133.95% | 0.00% | 0.00% | 0.00% | 0.33 | 0.72 | -1922.61 | -4.37 |
| OMI | Owens & Minor, Inc. | $2.68 | 207.07M | +942% | +49% | — | — | -2.12 | 1.36 | 0.07 | 48.40 | -0.28 | -0.72 | 20.74% | -1.94% | -3.39% | -48.70% | -7.35% | -7.44% | 3.79 | -1.44 | 1.08 | 0.39 | 35.40 | 76000.00% | 355.00% | -11251.00% | -8.69% | 0.09 | -2.36% | 0.00% | 0.00% | 0.00% | -13.75 | -42.87 | 0.27 | 2.30 |
| TKNO | Alpha Teknova, Inc. | $2.58 | 138.11M | +974% | -63% | — | — | -7.38 | 1.85 | 3.14 | -13.45 | — | 2.24 | 33.17% | -41.90% | -42.59% | -22.83% | -21.20% | -15.52% | 0.22 | -23.91 | 4.58 | 1.40 | -0.91 | -4386.00% | 735.00% | -3170.00% | -7.25% | -1.07 | -11.53% | 0.00% | 0.00% | 13.58% | -8.04 | -14.79 | 3.37 | 0.52 |
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
- CEO
- Luc Mongeau
- Employees
- 1.03K
- Beta
- 2.40
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.68 ÷ $1.13) − 1 = -39.82% (DCF, example).